{"product_id":"bauschhealth-business-model-canvas","title":"Bausch Health Companies Business Model Canvas","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrategic Business Model Canvas: value propositions, partners, revenue levers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eUnlock the strategic blueprint behind Bausch Health Companies with a concise Business Model Canvas revealing its value propositions, key partners, and revenue mechanics. This snapshot pinpoints growth levers and risks for investors and strategists. Purchase the full, editable Word\/Excel canvas for a section-by-section playbook to inform decisions and drive competitive advantage.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eartnerships\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAPI and excipient suppliers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eTrusted API and excipient suppliers ensure continuity across branded, generic and OTC lines by maintaining multiple qualified sources—typically 3+ suppliers per critical input—and 3–5 year supply contracts to support cost predictability and scale. Multi-sourcing mitigates shortages and price volatility; routine cGMP audits and formal quality agreements (performed annually or per regulatory cadence) safeguard compliance.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCMOs and CROs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eCMOs expand Bausch Health’s capacity and flexibility across dosage forms and devices, lowering fixed capital needs and enabling scale without major plant investment. CROs accelerate clinical and post-market studies in eye health, GI, and dermatology, with the global CRO market reaching about 79 billion USD in 2024. These partnerships shorten time-to-market and shift costs to variable spend. Rigorous quality oversight preserves regulatory compliance across jurisdictions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHealthcare providers and KOL networks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eCollaborations with ophthalmologists, gastroenterologists, dermatologists and KOLs steer clinical development and labeling, ensuring indication alignment with specialist practice. Real-world evidence programs support reimbursement and drive adoption by demonstrating effectiveness in routine care. Targeted educational initiatives train clinicians on appropriate use and safety. Continuous feedback loops from these partners inform lifecycle management and line extensions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDistributors, wholesalers, and pharmacies\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eAllied distributors, wholesalers, and pharmacies extend Bausch Healths reach into retail, hospital, and specialty settings, supporting broad patient access; in 2024 Bausch Health reported roughly $7.0 billion in net revenue, underscoring channel importance. Service-level agreements secure inventory, cold-chain integrity, and returns management to meet stringent compliance. Data-sharing with partners improves demand planning and adherence programs while co-promotion and in-store activation drive product uptake.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eChannel reach: retail, hospital, specialty\u003c\/li\u003e\n\u003cli\u003eOperations: SLA-backed inventory, cold-chain, returns\u003c\/li\u003e\n\u003cli\u003eValue: shared data for forecasting and adherence\u003c\/li\u003e\n\u003cli\u003eGrowth: co-promotion and in-store activation\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRegulators and reimbursement bodies\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eRegulators and reimbursement bodies (FDA, EMA, Health Canada and others) are core partners for Bausch Health, streamlining submissions and inspections and accelerating time-to-market; in 2024 regulatory engagement supported multiple lifecycle submissions across major markets. Payer and PBM relationships shape formulary access and pricing corridors, directly affecting net realized prices. Health technology assessments in Europe and other regions validate value messaging while compliance partners reduce cross-market regulatory and commercial risk.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eRegulatory engagement: FDA, EMA, Health Canada\u003c\/li\u003e\n\u003cli\u003ePayers\/PBMs: formulary influence, pricing corridors\u003c\/li\u003e\n\u003cli\u003eHTA: supports value dossiers across \u0026gt;20 markets\u003c\/li\u003e\n\u003cli\u003eCompliance partners: reduce inspection and pricing risk\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePartnerships, CRO scale (\u003cstrong\u003e~79B\u003c\/strong\u003e), distributors enable $7.0B, HTA in \u0026gt;20 markets\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eKey partnerships secure multi-sourced APIs\/excipients (3+ qualified suppliers, 3–5y contracts) and CMO\/CRO capacity to flex production and outsource clinical work (global CRO market ~79B USD in 2024). Clinician\/KOL collaborations and RWE support uptake and reimbursement; distributors drive access across retail, hospital and specialty channels (2024 net revenue ~7.0B USD). Regulators, payers and HTA (\u0026gt;20 markets) shape access and pricing.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003ePartner\u003c\/th\u003e\n\u003cth\u003eRole\u003c\/th\u003e\n\u003cth\u003e2024 metric\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eSuppliers\u003c\/td\u003e\n\u003ctd\u003eContinuity, quality\u003c\/td\u003e\n\u003ctd\u003e3+ suppliers, 3–5y contracts\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCMO\/CRO\u003c\/td\u003e\n\u003ctd\u003eCapacity, trials\u003c\/td\u003e\n\u003ctd\u003eCRO market ~79B USD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDistributors\u003c\/td\u003e\n\u003ctd\u003eAccess, logistics\u003c\/td\u003e\n\u003ctd\u003eSupports $7.0B revenue\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRegulators\/Payers\u003c\/td\u003e\n\u003ctd\u003eAccess, pricing\u003c\/td\u003e\n\u003ctd\u003eHTA in \u0026gt;20 markets\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eA comprehensive Business Model Canvas for Bausch Health Companies outlining customer segments, channels, value propositions, key activities, partners, resources, cost structure and revenue streams, reflecting real-world pharma and consumer-health operations. Ideal for presentations and investor discussions, it includes competitive advantages and SWOT-linked insights organized across the nine BMC blocks.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eHigh-level Business Model Canvas for Bausch Health Companies that condenses strategy into a single editable page, quickly identifying core components and relieving pain from scattered strategy documents. Perfect for fast executive summaries, team collaboration, and side-by-side comparisons to streamline decision-making.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eA\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003ectivities\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eR\u0026amp;D and clinical development\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eR\u0026amp;D and clinical development center on advancing a 2024 pipeline focused on ophthalmology, gastroenterology, and dermatology, with activities across preclinical, clinical trials, and post-marketing studies to support label expansions. Label expansions and device iterations sustain differentiation, while pharmacovigilance programs monitor safety and real-world outcomes. In 2024 Bausch Health invested about $360 million in R\u0026amp;D to drive these programs and trial progress.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eManufacturing and quality operations\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAs of 2024, Bausch Health uses in-house plants and CMOs across North America, Europe and Asia to produce pharmaceuticals and medical devices under cGMP and ISO standards. Process validation, sterility assurance and device assembly are critical controls. Continuous improvement programs target yield gains and cost efficiencies. Global QA\/RA oversees compliance, regulatory submissions and supplier audits.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRegulatory and market access\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003ePreparation of dossiers, responses and variations underpins approvals, supporting Bausch Healths 2024 product launches and lifecycle management after a year with reported revenue near $8.1 billion. Pricing, tendering and payer negotiations drive market access and net price realization in key markets where formulary placement determines volume. Coding and reimbursement pathways are secured to support uptake and outpatient access. Post-approval commitments and pharmacovigilance maintain licenses and market presence.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBrand and portfolio management\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eLifecycle management optimizes brands across geographies and channels, leveraging generics, OTC switches and line extensions to defend share; in 2024 Bausch Health concentrated portfolio actions on high-margin eye care and dermatology franchises.\u003c\/p\u003e\n\u003cp\u003eTargeted medical education and field force deployment drive HCP adoption, while digital assets and patient engagement platforms expanded reach in 2024 to support adherence and real-world evidence collection.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003ePortfolio focus: generics\/OTC\/line extensions\u003c\/li\u003e\n\u003cli\u003eCommercial tactics: medical education + field force\u003c\/li\u003e\n\u003cli\u003eDigital: patient\/HCP engagement, RWE capture\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSupply chain and distribution\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eSupply chain and distribution at Bausch Health rely on S\u0026amp;OP and forecasting to sustain \u0026gt;98% service levels and optimize inventory turns, while inventory control limits stockouts for core ophthalmics and dermatology lines. Cold-chain and specialty logistics handle temperature-sensitive biologics and small-molecule injectables, covering roughly 20% of SKU value. Anti-counterfeit measures and serialization protect patients and brand by enabling unit-level traceability; returns and chargeback workflows manage channel economics and compress margins by about 3%.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eService level: \u0026gt;98%\u003c\/li\u003e\n\u003cli\u003eCold-chain SKU value: ~20%\u003c\/li\u003e\n\u003cli\u003eSerialization: unit-level traceability\u003c\/li\u003e\n\u003cli\u003eChannel margin impact: ~3%\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eR\u0026amp;D-led biopharma: \u003cstrong\u003e$8.1B\u003c\/strong\u003e revenue, \u003cstrong\u003e$360M\u003c\/strong\u003e R\u0026amp;D\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eBausch Health centers on R\u0026amp;D and lifecycle management (2024 R\u0026amp;D spend ~$360M) to advance ophthalmology, gastroenterology and dermatology pipelines, support label expansions and post-marketing safety. Manufacturing via in-house plants and CMOs across NA\/EU\/ASIA maintains cGMP\/ISO quality, serialization and cold-chain (~20% SKU value) to protect supply and traceability. Commercial activities drive access and uptake, with 2024 revenue ~8.1B, service levels \u0026gt;98% and channel margin leakage ~3%.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct\" green_head blur_tbl\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024 Value\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eR\u0026amp;D spend\u003c\/td\u003e\n\u003ctd\u003e$360M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRevenue\u003c\/td\u003e\n\u003ctd\u003e$8.1B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eService level\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;98%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCold-chain SKU value\u003c\/td\u003e\n\u003ctd\u003e~20%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eChannel margin impact\u003c\/td\u003e\n\u003ctd\u003e~3%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eWhat You See Is What You Get\u003c\/span\u003e\u003cbr\u003e Business Model Canvas\u003c\/h2\u003e\n\u003cp\u003eThe document you're previewing is the actual Bausch Health Companies Business Model Canvas. It’s not a mockup—this is the identical file you’ll receive after purchase. Upon buying, you’ll download the complete, editable document formatted for immediate use.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"PortersFiveForce","offers":[{"title":"Default Title","offer_id":55674919977337,"sku":"bauschhealth-business-model-canvas","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0914\/5276\/8633\/files\/bauschhealth-business-model-canvas.png?v=1755798579","url":"https:\/\/portersfiveforce.com\/products\/bauschhealth-business-model-canvas","provider":"Porter's Five Forces","version":"1.0","type":"link"}